Tension mounts as Evonik presses ahead

The decision to launch the €3.5bn-€5bn IPO of Evonik last Friday morning generated mixed reviews from ECM bankers with some worried that Europe’s flagship transaction will be a hostage to market and political sentiment. This week, reports that Rothschild has been added as a second adviser stoked suggestions of tension among the parties involved.

  • 01 Jun 2012

"This process has had a lot of tension, a lot of finger-pointing, that you can see in the leaks and briefings in the German press," said one ECM banker. "I still think it will get done. The key is whether or not the extensive cornerstone/anchor process works."

RAG-Stiftung, which ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 325,692.23 1268 8.08%
2 JPMorgan 318,171.08 1387 7.90%
3 Bank of America Merrill Lynch 293,301.12 1008 7.28%
4 Barclays 245,918.13 920 6.10%
5 Goldman Sachs 217,162.09 730 5.39%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 45,688.28 179 7.05%
2 JPMorgan 43,572.44 88 6.72%
3 UniCredit 35,452.34 152 5.47%
4 Credit Agricole CIB 33,170.05 159 5.12%
5 SG Corporate & Investment Banking 32,244.80 125 4.97%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 14 Nov 2018
1 JPMorgan 13,643.79 60 8.96%
2 Goldman Sachs 13,204.47 65 8.68%
3 Citi 9,716.40 55 6.38%
4 Morgan Stanley 8,471.86 53 5.57%
5 UBS 8,136.41 33 5.35%